Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients.
about
Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Daclizumab has poor efficacy i ...... ce with 12 allograft patients.
@en
Daclizumab has poor efficacy i ...... ce with 12 allograft patients.
@nl
type
label
Daclizumab has poor efficacy i ...... ce with 12 allograft patients.
@en
Daclizumab has poor efficacy i ...... ce with 12 allograft patients.
@nl
prefLabel
Daclizumab has poor efficacy i ...... ce with 12 allograft patients.
@en
Daclizumab has poor efficacy i ...... ce with 12 allograft patients.
@nl
P2093
P2860
P356
P1476
Daclizumab has poor efficacy i ...... ce with 12 allograft patients.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705927
P407
P577
2007-11-19T00:00:00Z